Last Update 13 May 26

Fair value Decreased 4.80%

ACI: Cost Control And Capital Returns Will Support Earnings Resilience Despite Sector Caution

Narrative Update

Albertsons Companies' updated analyst price target of $21, slightly below the prior fair value estimate of about $22.06, reflects analysts' recent target cuts that incorporate a higher discount rate, more cautious revenue growth and margin expectations, and a modestly adjusted future P/E assumption.

Analyst Commentary

Recent Street research on Albertsons Companies has leaned toward more cautious pricing assumptions, with several firms trimming their price targets and one raising its target slightly. For you as an investor, the key themes are how analysts see the balance between execution risk, margin pressure, and what they view as a fair multiple for the stock.

Bullish Takeaways

Bullish analysts highlight that Albertsons still supports a price target of around US$20, which implies they see the current earnings profile as reasonably supported by existing operations and capital allocation.
The increase in one target from US$19 to US$20 signals some confidence that recent execution trends, such as cost control and store productivity, can sustain current valuation levels.
Maintaining an "In Line" style rating alongside a higher target suggests that at least some on the Street see the stock as roughly fairly valued rather than structurally impaired, which can anchor sentiment during periods of heightened uncertainty.

Bearish Takeaways

Bearish analysts have cut price targets by US$1 to US$4, which points to reduced conviction in prior assumptions around margins, revenue trajectory, or the appropriate P/E they are willing to assign.
The decision by JPMorgan to cut its target and remove Albertsons from its Analyst Focus List indicates a shift toward viewing other stocks as having more attractive risk reward, even if the fundamental rating on Albertsons itself is not necessarily negative.
Target reductions clustered within a short time frame suggest a shared concern that prior expectations may have been too optimistic on execution, leaving less room for error in areas like costs, pricing, or competitive intensity.
Collectively, the lower targets contribute to a compressed valuation range around the stock, which can cap upside in the near term if earnings or cash flow do not clearly outperform current Street assumptions.

What's in the News

Albertsons agreed to a US$774 million nationwide settlement to resolve allegations related to its role in the opioid epidemic, with funds to be distributed to states, local governments, and Native American tribes as part of broader opioid litigation recoveries totaling more than US$60b across parties involved (Lawsuits & Legal Issues).
Albertsons Media Collective introduced onsite incrementality measurement to help advertisers assess the causal impact of onsite display media on sales, using test and control frameworks and highlighting campaign results such as a reported $7.45 iROAS, 65% new to brand buyers, and a 33% lift in sales for S. Martinelli & Co (Product Related Announcements).
The company issued fiscal 2026 earnings guidance that includes an identical sales growth range of 0.0% to 1.0% (Corporate Guidance).
The Board of Directors declared a first quarter fiscal 2026 cash dividend of US$0.17 per share, implying an annualized US$0.68 per share dividend, compared with an initial post IPO annualized level of US$0.40 per share (Dividend Increases).
Albertsons increased its share repurchase authorization from US$900 million remaining to US$2.0b, expanding the capacity of its equity buyback plan (Buyback Change in Plan Terms).

Valuation Changes

Fair Value: trimmed from $22.06 to $21.00, a reduction of about 4.8% in the modeled fair value estimate.
Discount Rate: increased slightly from 9.76% to 10.05%, which raises the required return used in the valuation work.
Revenue Growth: assumed dollar revenue growth rate lowered from 1.52% to 0.83%, indicating a more cautious forward sales outlook in the model.
Net Profit Margin: projected margin adjusted from 1.25% to 1.15%, a modest reduction in expected profitability on each dollar of sales.
Future P/E: target future P/E multiple moved marginally higher from 11.27x to 11.38x, a small change in the valuation multiple applied to earnings.

7 views

Key Takeaways

Growth in digital channels, health offerings, and loyalty programs is enhancing customer engagement, retention, and overall sales momentum.
Technology upgrades, private label expansion, and omnichannel integration are strengthening margins, operational efficiency, and competitive positioning.
Margin and earnings growth are pressured by lagging e-commerce, rising labor costs, pharmacy mix headwinds, stiff competition, and slow realization of cost-saving initiatives.

Catalysts

About Albertsons Companies

Through its subsidiaries, operates in the food and drug retail industry in the United States.What are the underlying business or industry changes driving this perspective?

Accelerating growth in digital channels-including a 25% surge in e-commerce sales and a robust loyalty program-strongly positions Albertsons to capitalize on rising consumer demand for convenience and online grocery ordering, supporting higher future revenue and customer retention.
Expansion and integration of pharmacy and health offerings (20% YoY growth), with enhanced digital cross-shopping, is increasing customer engagement, driving more frequent visits, and boosting overall basket size, directly benefiting top-line sales and increasing customer lifetime value.
Modernization through technology investments-such as automation, AI-driven inventory/pricing, and centralized buying-are streamlining operations, reducing labor and supply chain costs, and positioning the company for long-term margin expansion and improved net earnings.
Increasing penetration of private label and own brands (now at 25.7% of sales with a push to reach 30%+), along with targeted value investments, are driving higher-margin sales, deepening brand loyalty, and contributing to gross margin stabilization over time.
Leveraging omnichannel capabilities and integrated digital experiences is enabling Albertsons to better compete for market share amidst urbanization and evolving health and wellness trends, which supports sustained same-store sales growth and overall top-line momentum.

Albertsons Companies Earnings and Revenue Growth

Albertsons Companies Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Albertsons Companies's revenue will remain fairly flat over the next 3 years.
Analysts assume that profit margins will increase from 0.3% today to 1.1% in 3 years time.
Analysts expect earnings to reach $976.7 million (and earnings per share of $2.37) by about May 2029, up from $217.4 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $1.1 billion.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 11.4x on those 2029 earnings, down from 36.2x today. This future PE is lower than the current PE for the US Consumer Retailing industry at 17.7x.
Analysts expect the number of shares outstanding to decline by 7.0% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 10.05%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Albertsons' e-commerce business, though growing at 25% year-over-year, still lags industry peers in penetration, and reaching breakeven profitability remains a challenge; a persistent gap or inability to scale digital efficiently could result in continued pressure on net margins and limit overall earnings growth.
Rising labor costs and ongoing union contract negotiations, as evidenced by 120,000 associates potentially affected in FY25 and a focus on improved wages and benefits, pose long-term risks of margin compression and higher SG&A expense, which could negatively impact net income.
The grocery industry's highly competitive landscape-marked by sustained price investments, heavy promotional activity, and mounting pressure from mass, club, and discount value players (as well as non-traditional entrants like Amazon and Dollar General)-threatens to erode Albertsons' pricing power and market share, squeezing revenue growth and profitability.
Growth is increasingly driven by the pharmacy segment (notably from high-priced GLP-1 drugs) rather than core grocery sales, but pharmacy often carries lower profitability and creates sustained mix headwinds for gross margin; over-reliance on this trend exposes future revenue and margin risk if pharmacy growth normalizes or reimbursement rates tighten.
Despite technology and productivity investments, the company's near-term gross margin is under pressure as savings from supply chain efficiencies and national buying only gradually materialize, while aggressive investment in price and customer value is required to support unit growth; this mismatch could delay or dampen EBITDA and earnings growth in the face of inflation and secular consumer shifts towards value and healthier specialty foods.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $21.0 for Albertsons Companies based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $26.0, and the most bearish reporting a price target of just $14.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $85.3 billion, earnings will come to $976.7 million, and it would be trading on a PE ratio of 11.4x, assuming you use a discount rate of 10.0%.
Given the current share price of $15.92, the analyst price target of $21.0 is 24.2% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Albertsons Companies?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

ACI: Digital Integration And Customer Engagement Will Drive Outperformance Beyond 2025